Clearstead Advisors, LLC - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 110 filers reported holding TRANSMEDICS GROUP INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
Clearstead Advisors, LLC ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q3 2023$16,426
+30.4%
300
+100.0%
0.00%
-100.0%
Q2 2023$12,597
+10.9%
1500.0%0.00%0.0%
Q1 2023$11,360
+22.7%
1500.0%0.00%0.0%
Q4 2022$9,258
+54.3%
1500.0%0.00%0.0%
Q3 2022$6,000
+20.0%
1500.0%0.00%
Q2 2022$5,000
+25.0%
1500.0%0.00%
Q1 2022$4,000
+33.3%
1500.0%0.00%
Q4 2021$3,000
-40.0%
1500.0%0.00%
Q3 2021$5,0000.0%1500.0%0.00%
Q2 2021$5,000
-16.7%
1500.0%0.00%
Q1 2021$6,0001500.00%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q1 2022
NameSharesValueWeighting ↓
Must Asset Management Inc. 94,202$5,168,86312.65%
Eagle Health Investments LP 414,205$22,677,7245.00%
Ophir Asset Management Pty Ltd 295,761$16,192,9153.82%
Sandhill Capital Partners LLC 732,610$40,110,4093.75%
First Light Asset Management, LLC 618,100$33,840,9753.21%
NEXT CENTURY GROWTH INVESTORS LLC 477,482$26,142,1392.84%
Bullseye Asset Management LLC 70,512$3,8612.15%
Kent Lake Capital LLC 100,000$5,475,0002.10%
Nicholas Investment Partners, LP 413,714$22,650,8421.69%
AtonRa Partners 12,287$672,7131.41%
View complete list of TRANSMEDICS GROUP INC shareholders